ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant.

April 16, 2004